Lucy Lu
2018 - AVENUE THERAPEUTICS
In 2018, Lucy Lu earned a total compensation of $1.6M as Chief Executive Officer at AVENUE THERAPEUTICS, a 22% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $315,309 |
|---|---|
| Salary | $406,850 |
| Stock Awards | $865,000 |
| Other | $7,474 |
| Total | $1,594,633 |
Lu received $865K in stock awards, accounting for 54% of the total pay in 2018.
Lu also received $315.3K in non-equity incentive plan, $406.9K in salary and $7.5K in other compensation.
Rankings
In 2018, Lucy Lu's compensation ranked 6,873rd out of 14,244 executives tracked by ExecPay. In other words, Lu earned more than 51.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,873 out of 14,244 | 52nd |
Division Manufacturing | 2,635 out of 5,759 | 54th |
Major group Chemicals And Allied Products | 993 out of 2,122 | 53rd |
Industry group Drugs | 834 out of 1,811 | 54th |
Industry Pharmaceutical Preparations | 651 out of 1,385 | 53rd |
Source: SEC filing on April 30, 2019.
Lu's colleagues
We found two more compensation records of executives who worked with Lucy Lu at AVENUE THERAPEUTICS in 2018.
News
AVENUE THERAPEUTICS CEO Lucy Lu's 2021 pay jumps 144% to $1.1M
November 18, 2022
AVENUE THERAPEUTICS CEO Lucy Lu's 2020 pay falls 31% to $443K
November 23, 2021
AVENUE THERAPEUTICS CEO Lucy Lu's 2019 pay falls 60% to $640K
April 29, 2020
AVENUE THERAPEUTICS CEO Lucy Lu's 2018 pay falls 22% to $1.6M
April 30, 2019